ArticleThe British journal of dermatology2022

Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies.

Afsaneh Alavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.